Evidence map›Paper›PMID 40294154›Full record

ArticlePLoS biology2025

Activation of the Drosophila innate immune system accelerates growth in cooperation with oncogenic Ras.

Fabienne Brutscher, Federico Germani, George Hausmann, Lena Jutz, Konrad Basler

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Functions ofFrontiers in cell and developmental biology · 2025
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Fabienne BrutscherDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0009-0008-9161-0571
Federico GermaniDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
George HausmannDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Lena JutzDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Konrad BaslerDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-3534-1529

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innate immunity in Drosophila acts as an organismal surveillance system for external stimuli or cellular fitness and triggers context-specific responses to fight infections and maintain tissue homeostasis. However, uncontrolled activation of innate immune pathways can be detrimental. In mammals, innate immune signaling is often overactivated in malignant cells and contributes to tumor progression. Drosophila tumor models have been instrumental in the discovery of interactions between pathways that promote tumorigenesis, but little is known about whether and how the Toll innate immune pathway interacts with oncogenes. Here we use a Drosophila epithelial in vivo model to investigate the interplay between Toll signaling and oncogenic Ras. In the absence of oncogenic Ras (RasV12), Toll signaling suppresses differentiation and induces apoptosis. In contrast, in the context of RasV12, cells are protected from cell death and Dorsal promotes cell survival and proliferation to drive hyperplasia. Taken together, we show that the tissue-protective functions of innate immune activity can be hijacked by pre-malignant cells to induce tumorous overgrowth.

Indexed as

Drosophila melanogasterImmunity, Innateras ProteinsAnimalsApoptosisCell DifferentiationCell ProliferationDrosophila ProteinsSignal TransductionToll-Like ReceptorsDrosophila Proteinsras ProteinsTl protein, DrosophilaToll-Like Receptors

Identifiers

PMID40294154
PMCPMC12036928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.